Pathogenesis of the antiphospholipid syndrome

Area of Science:

• Immunology
• Pathophysiology
• Reproductive Medicine

Background:

• Antiphospholipid antibodies (aPL) characterize antiphospholipid syndrome (APS).
• aPL mediate pregnancy loss and thrombosis via antigenic targets.
• Mechanisms of aPL-induced procoagulant and placental pathology are not fully understood.

Purpose of the Study:

• Review current knowledge on pathogenic aPL origins.
• Elucidate mechanisms of aPL action on target antigens.
• Examine phenotyping for targeted APS therapies.

Main Methods:

• Literature review of antiphospholipid syndrome.
• Analysis of pathogenic antibody ontogeny.
• Exploration of pathophysiological mechanisms in APS.

Main Results:

• Inflammation links aPL procoagulant effects to thrombosis.
• aPL contribute to placental injury in APS.
• Understanding aPL origins is crucial for targeted treatment.

Conclusions:

• Further research into aPL ontogeny and mechanisms is needed.
• Classifying APS patients by phenotype may enable targeted therapies.
• Novel therapeutic strategies could improve APS management.